EcoDrugPlus

Tyrosine Hydroxylase

Ensembl ID : ENSPPRG00000013064
Gene Symbol: TH
4 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSPPRG00000012402
Gene Symbol: TYK2
4 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSPPRG00000001962
Gene Symbol: TIE1
4 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSPPRG00000023621
Gene Symbol: UTRN
4 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSPPRG00000004713
Gene Symbol: VEGFA
3 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSPPRG00000007108
Gene Symbol: VDR
4 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSPPRG00000008475
Gene Symbol: VKORC1
3 Cross references
186 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like

Ensembl ID : ENSPPRG00000007873
Gene Symbol: LOC109261808
2 Cross references
187 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSPPRG00000002259
Gene Symbol: XDH
3 Cross references
208 Possible Orthologues:

Ensembl ID : ENSPPRG00000012038
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSPPRG00000011197
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSPPRG00000017379
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).